These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7717060)

  • 1. Pharmacokinetic-pharmacodynamic modeling of electroencephalographic effects of midazolam in eight Chinese men.
    Lu JF; Chen G; Xiang BR; An DK
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):399-403. PubMed ID: 7717060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
    Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
    Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.
    Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
    Clin Pharmacokinet; 1990 Mar; 18(3):245-53. PubMed ID: 2323155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midazolam pharmacokinetics and electroencephalographic changes in eight Chinese men.
    Lu JF; Wu MF; Chen G; Xiang BR; An DK
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):485-8. PubMed ID: 8010043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
    Mandema JW; Kuck MT; Danhof M
    J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
    Mandema JW; Tukker E; Danhof M
    J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity.
    Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M
    J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats.
    Della Paschoa OE; Mandema JW; Voskuyl RA; Danhof M
    J Pharmacol Exp Ther; 1998 Feb; 284(2):460-6. PubMed ID: 9454785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
    Cox EH; Kuipers JA; Danhof M
    Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.
    Hardmeier M; Zimmermann R; Rüegg S; Pflüger M; Deuster S; Suter K; Donzelli M; Drewe J; Krähenbühl S; Fuhr P; Haschke M
    Clin Pharmacol Ther; 2012 May; 91(5):856-62. PubMed ID: 22453191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
    Mandema JW; Tukker E; Danhof M
    Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam.
    Mould DR; DeFeo TM; Reele S; Milla G; Limjuco R; Crews T; Choma N; Patel IH
    Clin Pharmacol Ther; 1995 Jul; 58(1):35-43. PubMed ID: 7628181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot pharmacokinetic-pharmacodynamic study of benzodiazepine antagonism by flumazenil and aminophylline.
    Bonfiglio MF; Fisher-Katz LE; Saltis LM; Traeger SM; Martin BR; Nackes NA; Perkins TA
    Pharmacotherapy; 1996; 16(6):1166-72. PubMed ID: 8947991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam.
    Tuk B; Herben VM; Mandema JW; Danhof M
    J Pharmacol Exp Ther; 1998 Jan; 284(1):202-7. PubMed ID: 9435179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats.
    Visser SA; Huntjens DR; van der Graaf PH; Peletier LA; Danhof M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):765-75. PubMed ID: 12975494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect.
    Billard V; Gambus PL; Chamoun N; Stanski DR; Shafer SL
    Clin Pharmacol Ther; 1997 Jan; 61(1):45-58. PubMed ID: 9024173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physostigmine reversal of midazolam-induced electroencephalographic changes in healthy subjects.
    Ebert U; Oertel R; Kirch W
    Clin Pharmacol Ther; 2000 May; 67(5):538-48. PubMed ID: 10824633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.